Acceptability Of RWD Must Be Decided On Case-By-Case Basis, Says EU Expert

 
• By Vibha Sharma
  
Capsule in mid-air on graphs and big data of the global diffusion of the new pharmaceutical drug.
Study objectives should focus on providing evidence for regulatory assessment • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography